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Personal Perspective
oxygen as part of continuous oxygen therapy in patie
criteria for long-term oxygen therapy — both to 
duration of normal blood oxygen concentrations and
exercise capacity.
Two of us (A J C, C F M) have been actively involv
around the issue of quality of life of patients on long
therapy.3-6 It has not yet been confirmed whethee w
(pa
upW elcome the incisive comments from Cahill Lambertge 472).1 The remit of our position statement2 was todate our previous evidence-based guidelines for the
prescription of oxygen in Australia and New Zealand by reviewing
the currently available literature. Informal consultation with con-
sumers was made through the Australian Lung Foundation’s
COPD (chronic obstructive pulmonary disease) Consultative
Group, but no funding was available to seek broader community







oxygen is of significant benefit in this area.7,8 The unwieldiness of
some of the currently available portable cylinders may counteract
some of the potential gains of using ambulatory oxygen, but we
have not been successful in securing the widespread use of liquid
oxygen in Australia. It is yet to be demonstrated that the extra costs
associated with a liquid oxygen system are balanced by greater
benefits in useability (portability and comfort) and quality of life.
Although we are keenly aware that there are major issues of
equity and access to ambulatory oxygen therapy across Australia,
as Cahill Lambert correctly asserts, discussing these issues was
outside the parameters (and space constraints) of our position
statement. While we may consider oxygen to be equivalent to a
“drug” for the purposes of this discussion, oxygen, unlike pharma-
ceuticals, is not a federally-funded commodity but is provided on a
state-by-state basis through programs such as the Victorian Aids
and Equipment Program (except in the case of war veterans, who
are funded through the Department of Veterans’ Affairs). Individ-
ual state funding arrangements have led to inequalities in the
provision of this service. It is our understanding that New South
Wales and Queensland do not currently supply portable oxygen to
adults requiring long-term continuous oxygen therapy delivered
by concentrator. However, Victoria, Tasmania, Western Australia
and South Australia provide portable oxygen cylinders to such
patients and to others who have demonstrable evidence of desat-
uration on exertion and measurable benefit from portable oxygen
therapy (in terms of improved exercise capacity or reduced
breathlessness). There are caps on supply, with only a certain
number of cylinders allowed per month in most instances. Cap-
ping, although understandable in fiscal terms, makes little sense to
patients trying to maximise their exercise capacity (and quality of
life) by exercising regularly with the help of ambulatory oxygen.
We recommended in our position statement that patients requir-
ing oxygen therapy should be assessed and reviewed on a regular
basis. Although not explicitly stated in our position statement, we
believe this review should be undertaken by the clinician manag-
ing the patient. We agree with Cahill Lambert that there is a
potential conflict of interest in the review being conducted by the
company supplying the oxygen. We support her call for more
advocacy in this area, but assure her that we have personally been
advocating for a fairer and more equitable system for many years.
Patient advocacy groups, such as those run through the Australian
Lung Foundation, as well as organisations such as the Thoracic
Society of Australia and New Zealand clearly have an important
role to play in ensuring that this issue makes its way onto the
political agenda.
We believe that further research is the key to providing more
definitive answers to some of the more contentious questions
around oxygen provision. Specific areas of research should include
portable oxygen use in patients not requiring continuous oxygen
therapy, nocturnal oxygen use in patients whose daytime resting
arterial blood gas levels would preclude them from receiving
continuous oxygen therapy, and the use of palliative oxygen
therapy in non-hypoxaemic patients. A more extensive body of
data in these areas would allow future updates of our position
statement to provide higher levels of evidence, which we hope
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